|Bid||52.10 x 800|
|Ask||54.96 x 800|
|Day's Range||51.85 - 53.18|
|52 Week Range||45.85 - 64.53|
|Beta (5Y Monthly)||0.92|
|PE Ratio (TTM)||13.71|
|Earnings Date||Feb 03, 2022 - Feb 07, 2022|
|Forward Dividend & Yield||1.98 (3.57%)|
|Ex-Dividend Date||Jun 30, 2022|
|1y Target Est||59.77|
Sometimes you just have to hold your nose and dive in, knowing that the near future may still dish out unnerving volatility.
Cardinal Health's (CAH) latest collaboration is expected to significantly boost its distribution strategy and improve patient service.
Cardinal Health (NYSE: CAH) today announced the launch of an inventory reserve program that helps labs and health systems more accurately pre-order respiratory diagnostics before the onset of seasonal flu, strep and RSV. This new program provides clearer demand signals to the supply chain ahead of the season, which helps reduce the friction felt across the healthcare landscape as the season ramps.